Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.
Azam C, Claraz P, Chevreau C, Vinson C, Cottura E, Mourey L, Pouessel D, Guibaud S, Pollet O, Le Goff M, Bardies C, Pelagatti V, Canonge JM, Puisset F.
Azam C, et al. Among authors: claraz p.
Eur J Clin Pharmacol. 2020 Apr;76(4):579-587. doi: 10.1007/s00228-020-02828-w. Epub 2020 Jan 13.
Eur J Clin Pharmacol. 2020.
PMID: 31932871